Previous COVID ‐19 Vaccination Modulates Type I Interferon and Natural Killer Cell Responses During SARS ‐ CoV ‐2 Infection
Journal of Cellular and Molecular Medicine · 2026
DOI: 10.1111/jcmm.71190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2026. Verfasst von Luca Maddaloni und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Killer Cells, Natural, COVID-19, SARS-CoV-2, Interferon Type I. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU funding within the NextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases.
Abstract (Originalsprache)
The impact of the SARS‐CoV‐2 vaccine on innate immunity is not well understood. However, it has played a pivotal role in reducing COVID‐19 severity and mortality. Recent findings have revealed that vaccine efficacy is influenced not only by the effective activation of adaptive immunity, but also by the modulation of innate immunity. This cross‐sectional study evaluates the natural killer (NK) cell response and its relationship with type I interferon (IFN‐I) gene expression in SARS‐CoV‐2‐infected patients who had previously received the anti‐spike vaccine, as well as in unvaccinated patients. Vaccinated individuals showed a higher frequency of NK CD56 dim CD16 − cells and increased IFN‐α2 and IFN‐ω mRNA expression ( p < 0.05). By contrast, unvaccinated patients displayed a predominance of NK CD56 dim CD16 + cells and reduced IFN‐I gene expression ( p < 0.05). A positive correlation was found between IFN‐I levels and the frequency of NK CD56 dim CD16 − cells and a negative correlation between IFN‐I levels and NK CD56 dim CD16 + cells. Furthermore, despite having more comorbidities, vaccinated patients had faster SARS‐CoV‐2 clearance, which reinforces the immunological advantage conferred by vaccination. Together, these findings suggest that the SARS‐CoV‐2 vaccine can modify the innate immune response by enhancing the NK cell response and increasing the magnitude of IFN‐I production during SARS‐CoV‐2 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
- Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
- Core Facilities, Istituto Superiore Di Sanità, Rome, Italy.
- Department of Molecular Medicine, Laboratory of Virology, Sapienza University of Rome, Rome, Italy.
- Azienda Ospedaliero Universitaria Policlinico Umberto I, Rome, Italy.
- Department of Molecular Medicine, Microbiology and Virology Laboratory, Sapienza University of Rome, Rome, Italy.
ORCID-Profile: Luca Maddaloni, Giancarlo Ceccarelli, Carolina Scagnolari, Gabriella d'Ettorre
Förderung
- EU funding within the NextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases
Zitieren
APA
Maddaloni, L., Tirelli, V., Bugani, G., Santinelli, L., Fracella, M., Picozza, M., Cavallari, E. N., Ceccarelli, G., Antonelli, G., Mastroianni, C. M., Scagnolari, C., & d'Ettorre, G. (2026). Previous COVID ‐19 Vaccination Modulates Type I Interferon and Natural Killer Cell Responses During SARS ‐ CoV ‐2 Infection. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.71190
Vancouver
Maddaloni L, Tirelli V, Bugani G, Santinelli L, Fracella M, Picozza M, et al. Previous COVID ‐19 Vaccination Modulates Type I Interferon and Natural Killer Cell Responses During SARS ‐ CoV ‐2 Infection. Journal of Cellular and Molecular Medicine. 2026. doi:10.1111/jcmm.71190
BibTeX
@article{Maddaloni2026,
author = {Maddaloni, Luca and Tirelli, Valentina and Bugani, Ginevra and Santinelli, Letizia and Fracella, Matteo and Picozza, Mario and Cavallari, Eugenio N and Ceccarelli, Giancarlo and Antonelli, Guido and Mastroianni, Claudio M and Scagnolari, Carolina and d'Ettorre, Gabriella},
title = {Previous COVID ‐19 Vaccination Modulates Type I Interferon and Natural Killer Cell Responses During SARS ‐ CoV ‐2 Infection},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
doi = {10.1111/jcmm.71190}
}
EUVIMED